Go Pro
NASDAQ:OXBR

Oxbridge Re Q4 2025 Earnings Report

Oxbridge Re logo
$1.38 -0.08 (-5.48%)
Closing price 07/29/2026 04:00 PM Eastern
Extended Trading
$1.50 +0.12 (+8.70%)
As of 07/29/2026 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Oxbridge Re EPS Results

Actual EPS
$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Oxbridge Re Revenue Results

Actual Revenue
$0.58 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Oxbridge Re Announcement Details

Quarter
Q4 2025
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Oxbridge Re's Q2 2026 earnings is estimated for Thursday, August 13, 2026, based on past reporting schedules, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Oxbridge Re Earnings Headlines

Oxbridge Re Holdings Ltd OXBR
ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I.
Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.tc pixel
See More Oxbridge Re Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Oxbridge Re? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oxbridge Re and other key companies, straight to your email.

About Oxbridge Re

Oxbridge Re (NASDAQ:OXBR) (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents. Oxbridge Re works closely with insurers to structure agreements that align risk retention levels, collateral requirements, and profit-sharing mechanics. These arrangements often feature customized features such as experience refunds, corridor enhancements, and risk corridors, providing clients with flexibility in managing long-term liabilities.

Oxbridge Re serves a diversified client base across North America, focusing primarily on life, annuity, and disability insurance portfolios. Its underwriting team brings experience in actuarial modeling, financial analysis, and regulatory compliance, supporting transactions that span single-life, group life, living benefits, and specialized guarantee products. While relatively new to the public markets, Oxbridge Re has built strategic alliances with financial institutions and reinsurers to broaden its capital resources and co‐reinsurance capabilities.

Governed by a board with backgrounds in insurance operations, capital markets, and risk management, Oxbridge Re emphasizes disciplined underwriting standards and capital-efficient structuring. The company aims to differentiate itself through innovative deal design and responsive client service, positioning its platform to address evolving regulatory requirements and competitive pressures within the reinsurance industry.

View Oxbridge Re Profile